Cardiogenic shock is a critical medical condition characterized by a sudden and severe decrease in the heart's ability to pump blood effectively, leading to insufficient oxygen delivery to vital organs. This condition typically arises from a massive heart attack, severe heart failure, or other cardiac events that compromise the heart's pumping function. As the heart's pumping capacity diminishes, blood pressure drops, and vital organs like the brain, kidneys, and lungs receive inadequate oxygen and nutrients. Common symptoms of cardiogenic shock include rapid breathing, cold and clammy skin, confusion, and a weak pulse. Immediate medical intervention is essential to address the underlying cause and restore blood flow. Treatment may involve medications to support heart function, mechanical support devices, or, in severe cases, emergency interventions such as angioplasty or coronary artery bypass surgery. Prompt recognition and intervention are crucial for improving the chances of survival and minimizing long-term complications associated with cardiogenic shock.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain